Radioiodine-resistant differentiated thyroid cancer: hope for the future
Hodak, S.P.; Carty, S.E.
Oncology 23(9): 775-776
2009
ISSN/ISBN: 0890-9091 PMID: 19777763 Document Number: 633336
Document emailed within 1 workday
Related Documents
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128Dietlein, M.; Dressler, J.; Farahati, J.; Leisner, B.; Moser, E.; Reiners, C.; Schicha, H.; Schober, O. 1999: Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer Nuklearmedizin. Nuclear Medicine 38(6a): 221-222
Saengsuda, Y. 2013: Radioiodine remnant ablation in low-risk differentiated thyroid cancer Journal of the Medical Association of Thailand 96(5): 614-624
Hasse-Lazar, K.; Handkiewicz-Junak, D.; Roskosz, Józef.; Szpak-Ulczok, S.; Krajewska, J.; Jurecka-Lubieniecka, B.; Jarzab, B. 2006: Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences Endokrynologia Polska 57(4): 445-450
Sriprapaporn, J.; Sethanandha, C.; Yingsa-nga, T.; Komoltri, C.; Thongpraparn, T.; Harnnanthawiwai, C. 2015: Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer Journal of the Medical Association of Thailand 98(6): 596-605
Bałdys-Waligórska, A.; Gołkowski, F.; Krzentowska-Korek, A.; Hubalewska-Dydejczyk, A. 2010: Radioiodine ablation of thyroid remnants in patients with differentiated thyroid carcinoma (DTC) following administration of rhTSH - a comparison with L-thyroxine withdrawal Endokrynologia Polska 61(5): 474-479
Zakani, A.; Saghari, M.; Eftekhari, M.; Fard-Esfahani, A.; Fallahi, B.; Esmaili, J.; Assadi, M. 2011: Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131i with emphasize on the thallium scintigraphy in these subgroups European Review for Medical and Pharmacological Sciences 15(10): 1215-1221
Ahn, B-Cheol. 2013: Radioiodine SPET/CT guided needle aspiration as a useful technique for recurrence surveillance in a thyroidectomized differentiated thyroid cancer patient with negative US and serum Tg and positive Tg of the lymph node aspirate Hellenic Journal of Nuclear Medicine 16(2): 142-143
Salvatori, M.; Rufini, V.; Garganese, M.C.; Di Giuda, D. 2000: Radioiodine therapy in differentiated thyroid carcinoma Rays 25(2): 221-238
Konrády, Aás. 2002: Radioiodine treatment of differentiated thyroid carcinomas: residual ablation Orvosi Hetilap 143(25): 1557; Author Reply
Claimon, A.; Pusuwan, P.; Khiewvan, B. 2017: Factors Influencing the Success of the first Radioiodine Therapy for Differentiated Thyroid Carcinoma Journal of the Medical Association of Thailand 100(2): 207-218
Ronga, G.; Toteda, M.; D'Apollo, R.; De Cristofaro, F.; Filesi, M.; Acqualagna, G.; Argirò, R.; Ciancamerla, M.; Ugolini, F.; Montesano, T. 2012: Lymph node metastases from differentiated thyroid carcinoma: does radioiodine still play a role? La Clinica Terapeutica 163(5): 377-381
Markou, P.; Chatzopoulos, D. 2004: Isolation period prediction in patients with differentiated thyroid carcinoma treated after thyroidectomy by radioiodine-131 Hellenic Journal of Nuclear Medicine 7(3): 195-198
Flynn, S.D.; Forman, B.H.; Stewart, A.F.; Kinder, B.K. 1988: Poorly differentiated ("insular") carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms Surgery 104(6): 963-970
Kusić, Z.; Jukić, T.; Dabelić, N.; Franceschi, M. 2008: Croatian Thyroid Society guidelines for the management of patients with differentiated thyroid cancer Lijecnicki vjesnik 130(9-10): 213-227
Schiavo, M.; Bagnara, M.C.; Pomposelli, E.; Altrinetti, V.; Calamia, I.; Camerieri, L.; Giusti, M.; Pesce, G.; Reitano, C.; Bagnasco, M.; Caputo, M. 2013: Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 301-307
Pietz, L.; Michałek, K.; Waśko, R.; Ruchała, M.; Sowiński, J. 2008: Influence of the endogene TSH stimulation of thyroid volume increase in the patients after total thyroidectomy due to differentiated thyroid cancer Endokrynologia Polska 59(2): 119-122
Horácek, Jí. 2015: Radioiodine therapy in patients with low-thyroid cancer Vnitrni Lekarstvi 61(9): 755-757
Dirr, W.; Pabst, H.W. 1982: Treatment of follicular thyroid cancer with radioiodine Schweizerische Rundschau für Medizin Praxis 71(13): 562-566
Roldán Schilling, V.; Fernández Abellán, P.; Domínguez Escribano, J.R.; Rivas González, C.; Mut Barberá, E.; Calatayud Cendra, R. 1998: Acute leukemias after treatment with radioiodine for thyroid cancer Haematologica 83(8): 767-768